While molecular mechanisms such as COL11A1 upregulation and MDR1-mediated drug efflux play central roles in chemoresistance, clinical and tumor related variables including: age, cancer subtype, and disease stage, also significantly influence therapeutic outcomes [53]. The gene discussed is COL11A1; the disease is cancer.